Biostax Corp (BTAX)

[locicat1]

As usual, your postings have great insight and provide the most appropriate background(s) for fruitful, sensible discussion about the status of IMUN.

Just one aside note--I would respectfully disagree with your opinion regarding the statins--but that is for another discussion.

Your summary is exactly correct re: IMUN's successful attainment of just one FDA approval to market for LDN. It would have been/still would be the initial "Bingo" for the company following the path just as you described. I have been indicating that in many of my postings here for well over a year!